BioCentury
ARTICLE | Company News

Hard to Treat Diseases, Walvax Biotech Co. Ltd. sales and marketing update

June 22, 2009 7:00 AM UTC

Hard to Treat Diseases' Mellow Hope Bio Chem China division signed an international marketing agreement to market Walvax's Haemophilus influenza type B ( Hib) conjugate vaccine. Hard to Treat Diseases...